Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2)

Authors

Thierry Lobbedez (ORCID: https://orcid.org/0000-0002-0945-8056)
Maxence Ficheux
Jean‐Jacques Parienti (ORCID: https://orcid.org/0000-0002-4774-5590)
Marion Boulanger (ORCID: https://orcid.org/0000-0003-0900-1766)
Farzin Beygui (ORCID: https://orcid.org/0000-0003-2170-8983)
Dorothée Balayn
Antoine Lanot (ORCID: https://orcid.org/0000-0003-0178-7389)
Catherine Béchade (ORCID: https://orcid.org/0000-0003-2070-2993)
Antoine Morin (ORCID: https://orcid.org/0000-0003-0043-2391)
Marie Brionne
Laure Peyro‐Saint‐Paul (ORCID: https://orcid.org/0000-0003-0301-1058)
Blandine Lecrux
Manon Brossier
Chloé Peron

Institutions

Normandie Université (FR)
Centre Hospitalier Universitaire de Caen Normandie (FR)
Délégation Normandie (FR)
Université de Caen Normandie (FR)

Publication Details

Journal: BMJ Open
Published: 2024-09-01
DOI: https://doi.org/10.1136/bmjopen-2024-089353
Citations: 3
Primary Topic: Atrial Fibrillation Management and Outcomes
Type: article
Field-Weighted Citation Impact: 1.21

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2)

Thierry Lobbedez, Maxence Ficheux, Jean‐Jacques Parienti, Marion Boulanger et al.

Sep 1, 2024

3 citations

BMJ Open

Atrial Fibrillation Management and Outcomes

1.21

article

Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2)

Thierry Lobbedez, Maxence Ficheux, Jean‐Jacques Parienti, Marion Boulanger, Farzin Beygui, Dorothée Balayn, Antoine Lanot, Catherine Béchade, Antoine Morin, Marie Brionne, Laure Peyro‐Saint‐Paul, Blandine Lecrux, Manon Brossier, Chloé Peron

September 1, 2024article en

3 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 14(9)

Normandie Université (FR), Centre Hospitalier Universitaire de Caen Normandie (FR), Délégation Normandie (FR), Université de Caen Normandie (FR)

Good health and well-being

Openalex Percentile: Top 18%

Atrial Fibrillation Management and Outcomes

1.21

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2) — Thierry Lobbedez, Maxence Ficheux, et al. · BMJ Open (2024) | TGRS Research Map | TGRS